Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 11/2016

01-11-2016 | Otology

Protective role of misoprostol against cisplatin-induced ototoxicity

Authors: Murat Doğan, Halil Polat, Mehmet Yaşar, Altan Kaya, Ali Bayram, Fatma Şenel, İbrahim Özcan

Published in: European Archives of Oto-Rhino-Laryngology | Issue 11/2016

Login to get access

Abstract

Cis-diammineedichloroplatinum (cisplatin) is a chemotherapeutic agent that is widely used in the treatment of many cancers. Nephrotoxicity, ototoxicity and neurotoxicity are dose-limiting adverse effects for cisplatin. The cellular and molecular mechanisms underlying cisplatin-induced ototoxicity aren’t fully understood. It has been proposed that cisplatin primarily cause damage at the cochlea, outer hair cells in particular, leading to excessive production of free oxygen radicals in the organ of Corti, stria vascularis, spiral ligament, and spiral ganglionic cells. The cytotoxicity is associated with the generation of reactive oxygen species (ROS); thus, there is an increasing interest on antioxidants with an effort to discover the established protection against cisplatin-induced ototoxicity over time. Misoprostol (MP) has gained considerable interest as a reactive oxygen species scavenger in recent years. To best of our knowledge, there is no study about protective effect of MP, a prostaglandin E1 (PGE1) analogue, on cisplatin-induced ototoxicity. In our study, we show that protective effects of misoprostol on cisplatin-induced ototoxcity on rats.
Literature
1.
go back to reference Li Y, Womer RB, Silber JH (2004) Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose. Eur J Cancer 40:2445–2451CrossRefPubMed Li Y, Womer RB, Silber JH (2004) Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose. Eur J Cancer 40:2445–2451CrossRefPubMed
2.
go back to reference Sluyter S, Klis SF, de Groot JC, Smoorenburg GF (2003) Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery. Hear Res 185:49–56CrossRefPubMed Sluyter S, Klis SF, de Groot JC, Smoorenburg GF (2003) Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery. Hear Res 185:49–56CrossRefPubMed
3.
go back to reference Erdem T, Bayindir T, Filiz A, Iraz M, Selimoglu E (2012) The effect of resveratrol on the prevention of cisplatin ototoxicity. Eur Arch Otorhinolaryngol 269(10):2185–2188CrossRefPubMed Erdem T, Bayindir T, Filiz A, Iraz M, Selimoglu E (2012) The effect of resveratrol on the prevention of cisplatin ototoxicity. Eur Arch Otorhinolaryngol 269(10):2185–2188CrossRefPubMed
4.
go back to reference Yumusakhuylu AC, Yazici M, Sari M, Binnetoglu A, Kosemihal E, Akdas F, Sirvanci S, Yuksel M, Uneri C, Tutkun A (2012) Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs. Int J Pediatr Otorhinolaryngol 76:404–408CrossRefPubMed Yumusakhuylu AC, Yazici M, Sari M, Binnetoglu A, Kosemihal E, Akdas F, Sirvanci S, Yuksel M, Uneri C, Tutkun A (2012) Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs. Int J Pediatr Otorhinolaryngol 76:404–408CrossRefPubMed
5.
go back to reference Laurell G, Bagger-Sjoback D (1991) Dose-dependent inner ear changes after I.V. administration of cisplatin. J Otolaryngol 20:158–167PubMed Laurell G, Bagger-Sjoback D (1991) Dose-dependent inner ear changes after I.V. administration of cisplatin. J Otolaryngol 20:158–167PubMed
6.
go back to reference Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265–7279CrossRefPubMed Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265–7279CrossRefPubMed
7.
go back to reference Kim HJ, Lee JH, Kim SJ, Oh GS, Moon HD, Kwon KB, Park C, Park BH, Lee HK, Chung SY, Park R, So HS (2010) Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity. J Neurosci 30:3933–3946CrossRefPubMed Kim HJ, Lee JH, Kim SJ, Oh GS, Moon HD, Kwon KB, Park C, Park BH, Lee HK, Chung SY, Park R, So HS (2010) Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity. J Neurosci 30:3933–3946CrossRefPubMed
8.
go back to reference Lynch ED, Gu R, Pierce C, Kil J (2005) Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 201:81–89CrossRefPubMed Lynch ED, Gu R, Pierce C, Kil J (2005) Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 201:81–89CrossRefPubMed
9.
go back to reference Salam OM, Saleem AA, Omara EA, Hassan NS (2009) Hepatoprotective effects of MP and silymarin on carbon tetrachloride-induced hepatic damage in rats. Fundam Clin Pharmacol 23(2):179–188CrossRefPubMed Salam OM, Saleem AA, Omara EA, Hassan NS (2009) Hepatoprotective effects of MP and silymarin on carbon tetrachloride-induced hepatic damage in rats. Fundam Clin Pharmacol 23(2):179–188CrossRefPubMed
10.
go back to reference Yang H, Majno P, Morel P et al (2002) Prostaglandin E(1) protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation. Microvasc Res 64:94–103CrossRefPubMed Yang H, Majno P, Morel P et al (2002) Prostaglandin E(1) protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation. Microvasc Res 64:94–103CrossRefPubMed
11.
12.
go back to reference Rybak LP, Mukherjea D, Jajoo S, Ramkumar V (2009) Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J Exp Med 219:177–186CrossRefPubMedPubMedCentral Rybak LP, Mukherjea D, Jajoo S, Ramkumar V (2009) Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J Exp Med 219:177–186CrossRefPubMedPubMedCentral
14.
15.
go back to reference Lopez-Gonzalez MA, Guerrero JM, Rojas F, Delgado F (2000) Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants. J Pineal Res 28:73–80CrossRefPubMed Lopez-Gonzalez MA, Guerrero JM, Rojas F, Delgado F (2000) Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants. J Pineal Res 28:73–80CrossRefPubMed
16.
go back to reference Daldal A, Odabasi O, Serbetcioglu B (2007) The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Otolaryngol Head Neck Surg 137:747–752CrossRefPubMed Daldal A, Odabasi O, Serbetcioglu B (2007) The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Otolaryngol Head Neck Surg 137:747–752CrossRefPubMed
17.
go back to reference Kalkanis JG, Whitworth C, Rybak LP (2004) Vitamin E reduces cisplatin ototoxicity. Laryngoscope 114:538–542CrossRefPubMed Kalkanis JG, Whitworth C, Rybak LP (2004) Vitamin E reduces cisplatin ototoxicity. Laryngoscope 114:538–542CrossRefPubMed
18.
go back to reference Campbell KC, Meech RP, Rybak LP, Hughes LF (1999) D-Methionine protects against cisplatin damage to the stria vascularis. Hear Res 138:13–28CrossRefPubMed Campbell KC, Meech RP, Rybak LP, Hughes LF (1999) D-Methionine protects against cisplatin damage to the stria vascularis. Hear Res 138:13–28CrossRefPubMed
19.
go back to reference Feghali JG, Liu W, Van De Water TR (2001) l-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 111:1147–1155CrossRefPubMed Feghali JG, Liu W, Van De Water TR (2001) l-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 111:1147–1155CrossRefPubMed
20.
go back to reference Huang X, Whitworth CA, Rybak LP (2007) Ginkgo bilobaextract (EGb 761) protects against cisplatin-induced ototoxicity in rats. Otol Neurotol 28:828–833CrossRefPubMed Huang X, Whitworth CA, Rybak LP (2007) Ginkgo bilobaextract (EGb 761) protects against cisplatin-induced ototoxicity in rats. Otol Neurotol 28:828–833CrossRefPubMed
21.
go back to reference Lynch ED, Gu R, Pierce C, Kil J (2005) Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 201:81–89CrossRefPubMed Lynch ED, Gu R, Pierce C, Kil J (2005) Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 201:81–89CrossRefPubMed
22.
go back to reference Church MW, Blakley BW, Burgio DL, Gupta AK (2004) WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects. J Assoc Res Otolaryngol 5:227–237CrossRefPubMedPubMedCentral Church MW, Blakley BW, Burgio DL, Gupta AK (2004) WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects. J Assoc Res Otolaryngol 5:227–237CrossRefPubMedPubMedCentral
23.
go back to reference Hyppolito MA, de Oliveira JA, Rossato M (2006) Cisplatin ototoxicity and otoprotection with sodium salicylate. Eur Arch Otorhinolaryngol 263:798–803CrossRefPubMed Hyppolito MA, de Oliveira JA, Rossato M (2006) Cisplatin ototoxicity and otoprotection with sodium salicylate. Eur Arch Otorhinolaryngol 263:798–803CrossRefPubMed
24.
go back to reference Yazici ZM, Meric A, Midi A, Arınc YV, Kahya V, Hafız G (2012) Reduction of cisplatin ototoxicity in rats by oral administration of pomegranate extract. Eur Arch Otorhinolaryngol 269:45–52CrossRefPubMed Yazici ZM, Meric A, Midi A, Arınc YV, Kahya V, Hafız G (2012) Reduction of cisplatin ototoxicity in rats by oral administration of pomegranate extract. Eur Arch Otorhinolaryngol 269:45–52CrossRefPubMed
25.
go back to reference Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721–724CrossRefPubMed Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721–724CrossRefPubMed
26.
go back to reference Xu O, Liu Y, Li X, Yang Y, Zhang Z, Wang N, Zhang Y, Lu H (2011) Protective effects of Salvia miltiorrhiza against cisplatininduced ototoxicity in guinea pigs. Am J Otolaryngol 32:228–234CrossRefPubMed Xu O, Liu Y, Li X, Yang Y, Zhang Z, Wang N, Zhang Y, Lu H (2011) Protective effects of Salvia miltiorrhiza against cisplatininduced ototoxicity in guinea pigs. Am J Otolaryngol 32:228–234CrossRefPubMed
28.
go back to reference Kapusuz Z, Ozkırıs M, Kala M, Saydam L. Protective Role of Bilberry Extract Against Cisplatin Induced Ototoxicity in Rats. Indian J Otolaryngol Head Neck Surg 65(4):339–344. doi:10.1007/s12070-013-0642-x Kapusuz Z, Ozkırıs M, Kala M, Saydam L. Protective Role of Bilberry Extract Against Cisplatin Induced Ototoxicity in Rats. Indian J Otolaryngol Head Neck Surg 65(4):339–344. doi:10.​1007/​s12070-013-0642-x
30.
go back to reference Kelles M, Tan M, Kalcioglu MT, Toplu Y, Bulam N (2013) The protective effect of Chrysin against cisplatin-induced ototoxicity in rats. Indian J Otolaryngol Head Neck Surg. doi:10.1007/s12070-013-0695-x Kelles M, Tan M, Kalcioglu MT, Toplu Y, Bulam N (2013) The protective effect of Chrysin against cisplatin-induced ototoxicity in rats. Indian J Otolaryngol Head Neck Surg. doi:10.​1007/​s12070-013-0695-x
31.
go back to reference - Ozturk M, Ucar S, Sarı F, Erdogan S, Topdag M, Iseri M.(2013) Possible protective effect of sertraline against cisplatin-induced ototoxicity: an experimental study. Hindawi Publ Corp Sci World J vol, Article ID 523480, 5 pages 10.1155/2013/523480 - Ozturk M, Ucar S, Sarı F, Erdogan S, Topdag M, Iseri M.(2013) Possible protective effect of sertraline against cisplatin-induced ototoxicity: an experimental study. Hindawi Publ Corp Sci World J vol, Article ID 523480, 5 pages 10.​1155/​2013/​523480
32.
go back to reference Toplu Y, Parlakpinar H, Sapmaz E, Karatas E, Polat A, Kizilay A (2014) The protective role of Molsidomine on the cisplatin-induced ototoxicity. Indian J Otolaryngol Head Neck Surg (July–Sept 2014) 66(3):314–319. doi:10.1007/s12070-014-0718-2 Toplu Y, Parlakpinar H, Sapmaz E, Karatas E, Polat A, Kizilay A (2014) The protective role of Molsidomine on the cisplatin-induced ototoxicity. Indian J Otolaryngol Head Neck Surg (July–Sept 2014) 66(3):314–319. doi:10.​1007/​s12070-014-0718-2
33.
go back to reference Bayindir T, Iraz M, Kelles M, Kaya S, Tan M, Filiz A, Toplu Y, Kalcioglu MT (2014) The effect of beta glucan on cisplatin ototoxicity. Indian J Otolaryngol Head Neck Surg (Apr–Jun 2014) 66(2):131–134. doi:10.1007/s12070-013-0623-0 Bayindir T, Iraz M, Kelles M, Kaya S, Tan M, Filiz A, Toplu Y, Kalcioglu MT (2014) The effect of beta glucan on cisplatin ototoxicity. Indian J Otolaryngol Head Neck Surg (Apr–Jun 2014) 66(2):131–134. doi:10.​1007/​s12070-013-0623-0
34.
go back to reference Brunton LL, Lazo JS, Parker KI (2006) Goodman and Gilman’s the pharmacological basis of therapeutics. Mc Graw Hill Companies, New York Brunton LL, Lazo JS, Parker KI (2006) Goodman and Gilman’s the pharmacological basis of therapeutics. Mc Graw Hill Companies, New York
35.
go back to reference Gana TJ, Koo J, MacPherson BR (1992) Gross and histologic effects of topical misoprostol on canine gastric mucosa. Exp Toxicol Pathol 44:40–46CrossRefPubMed Gana TJ, Koo J, MacPherson BR (1992) Gross and histologic effects of topical misoprostol on canine gastric mucosa. Exp Toxicol Pathol 44:40–46CrossRefPubMed
36.
go back to reference Asako H, Kubes P, Wallace J, Wolf RE, Granger DN (1992) Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylate. Gastroenterology 103:146–152CrossRefPubMed Asako H, Kubes P, Wallace J, Wolf RE, Granger DN (1992) Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylate. Gastroenterology 103:146–152CrossRefPubMed
37.
go back to reference Andrews FJ, Malconenti-Wilson C, O’Brien PE (1994). Effect of nonsteroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa. Am J Physiol 266(4 pt 1):G657–G664 Andrews FJ, Malconenti-Wilson C, O’Brien PE (1994). Effect of nonsteroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa. Am J Physiol 266(4 pt 1):G657–G664
38.
go back to reference Widomski DL, Walsh RE, Baron DA et al (1991) Effects of the prostaglandin analogue misoprostol on inflammatory mediator release by human monocytes. Agents Actions 34:30–31CrossRefPubMed Widomski DL, Walsh RE, Baron DA et al (1991) Effects of the prostaglandin analogue misoprostol on inflammatory mediator release by human monocytes. Agents Actions 34:30–31CrossRefPubMed
39.
go back to reference Kim HJ, Kwak JY (1996) Effects of misoprostol on renal function and plasma enothelin-1 levels during early postoperative stage of living donor renal transplant recipients. Transplant Proc 1996(28):1207–1209 Kim HJ, Kwak JY (1996) Effects of misoprostol on renal function and plasma enothelin-1 levels during early postoperative stage of living donor renal transplant recipients. Transplant Proc 1996(28):1207–1209
40.
go back to reference Kawata R, Urade Y, Tachibana M, Mizukoshi O (1988) Prostaglandin synthesis by the cochlea. Prostaglandins 1988(35):173–184CrossRef Kawata R, Urade Y, Tachibana M, Mizukoshi O (1988) Prostaglandin synthesis by the cochlea. Prostaglandins 1988(35):173–184CrossRef
41.
go back to reference Briner W, House J, O’Leary M (1993) Synthetic prostaglandin E1 misoprostol as a treatment for tinnitus. Arch Otolaryngol Head Neck Surg 119:652–654CrossRefPubMed Briner W, House J, O’Leary M (1993) Synthetic prostaglandin E1 misoprostol as a treatment for tinnitus. Arch Otolaryngol Head Neck Surg 119:652–654CrossRefPubMed
42.
go back to reference Davies NM, Longstreth J, Jamali F (2001) Misoprostol therapeutics revisited. Pharmacotherapy 21(1):60–73 Davies NM, Longstreth J, Jamali F (2001) Misoprostol therapeutics revisited. Pharmacotherapy 21(1):60–73
43.
go back to reference Ozer MK, Halil A, Moncu MC, Savran M, Calapoglu M, Yesilot S, Candan IA et al (2011) Effects of misoprostol on cisplatininduced renal damage in rats. Food Chem Toxicol 49:1556–1559CrossRefPubMed Ozer MK, Halil A, Moncu MC, Savran M, Calapoglu M, Yesilot S, Candan IA et al (2011) Effects of misoprostol on cisplatininduced renal damage in rats. Food Chem Toxicol 49:1556–1559CrossRefPubMed
Metadata
Title
Protective role of misoprostol against cisplatin-induced ototoxicity
Authors
Murat Doğan
Halil Polat
Mehmet Yaşar
Altan Kaya
Ali Bayram
Fatma Şenel
İbrahim Özcan
Publication date
01-11-2016
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 11/2016
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-016-4031-4

Other articles of this Issue 11/2016

European Archives of Oto-Rhino-Laryngology 11/2016 Go to the issue